| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Sep 16, 2024 | Buy | $18.00 | 1,833,000 | 32,994,000 | 4,303,418 | Sep 18, 2024, 06:02 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 09, 2024 | Sale | $1.08 | 3,525,094 | 3,807,102 | 1,725,348 | Aug 13, 2024, 05:03 PM | |
| ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 22, 2024 | Option Exercise | $10.20 | 461,687 | 4,709,207 | 1,048,572 | Jul 24, 2024, 04:27 PM | |
| ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 22, 2024 | Buy | $12.00 | 8,333,333 | 99,999,996 | 8,693,579 | Jul 24, 2024, 04:27 PM | |
| ELYM | Eliem Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jun 27, 2024 | Buy | $3.84 | 13,008,546 | 49,952,816 | 23,521,757 | Jul 01, 2024, 09:29 PM | |
| AVTE | Aerovate Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jun 17, 2024 | Buy | $1.67 | 928,110 | 1,549,944 | 7,893,678 | Jun 20, 2024, 05:56 PM | |
| ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Apr 11, 2024 | Option Exercise | $5.32 | 1,408,450 | 7,499,996 | 13,840,034 | Apr 15, 2024, 04:15 PM | |
| ACRV | Acrivon Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Apr 11, 2024 | Option Exercise | $8.50 | 3,530,000 | 30,005,000 | 7,914,206 | Apr 15, 2024, 04:15 PM | |
| BOLD | Boundless Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Apr 02, 2024 | Buy | $16.00 | 312,500 | 5,000,000 | 1,884,787 | Apr 04, 2024, 04:15 PM | |
| NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 27, 2024 | Buy | $10.00 | 3,000,000 | 30,000,000 | 10,050,818 | Mar 29, 2024, 05:38 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 26, 2024 | Buy | $9.55 | 457,745 | 4,371,465 | 9,452,119 | Mar 27, 2024, 07:37 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 27, 2024 | Buy | $9.79 | 505,954 | 4,953,290 | 9,958,073 | Mar 27, 2024, 07:37 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 25, 2024 | Buy | $9.06 | 437,600 | 3,964,656 | 8,994,374 | Mar 27, 2024, 07:37 PM | |
| LENZ | LENZ Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 21, 2024 | Buy | $15.03 | 998,009 | 15,000,075 | 3,319,339 | Mar 25, 2024, 08:48 PM | |
| ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 04, 2024 | Buy | $15.35 | 1,350,000 | 20,722,501 | 12,431,584 | Mar 06, 2024, 05:40 PM | |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 12, 2024 | Option Exercise | $13.50 | 1,672,508 | 22,578,858 | 2,983,755 | Feb 14, 2024, 07:49 PM | |
| PEPG | PepGen Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09, 2024 | Buy | $10.64 | 2,557,593 | 27,212,790 | 9,179,273 | Feb 13, 2024, 04:33 PM | |
| TYRA | Tyra Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 06, 2024 | Option Exercise | $13.01 | 3,180,155 | 41,373,817 | 8,477,275 | Feb 08, 2024, 05:16 PM | |
| WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director | Dec 11, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 18,202,009 | Jan 17, 2024, 07:06 PM | |
| SLDB | Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jan 11, 2024 | Buy | $5.53 | 904,160 | 5,000,005 | 4,192,216 | Jan 12, 2024, 05:01 PM | |
| WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director | Dec 11, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 19,202,009 | Dec 13, 2023, 04:33 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Sep 21, 2023 | Buy | $3.03 | 2,700,000 | 8,183,526 | 8,556,774 | Sep 25, 2023, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Aug 29, 2023 | Buy | $6.20 | 3,750,000 | 23,249,999 | 5,856,774 | Aug 31, 2023, 05:26 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 18, 2023 | Buy | $9.00 | 1,777,778 | 16,000,002 | 5,135,683 | Aug 22, 2023, 05:01 PM | |
| ABOS | Acumen Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 21, 2023 | Buy | $7.75 | 5,161,290 | 39,999,998 | 13,043,179 | Jul 25, 2023, 04:30 PM | |
| JANX | Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 19, 2023 | Buy | $12.46 | 495,008 | 6,167,800 | 8,117,246 | Jul 21, 2023, 04:31 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 05, 2023 | Buy | $5.00 | 935,850 | 4,679,250 | 3,213,828 | Jul 07, 2023, 04:30 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 28, 2023 | Buy | $29.24 | 246,779 | 7,215,818 | 6,807,839 | Mar 30, 2023, 05:03 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 29, 2023 | Buy | $29.38 | 66,369 | 1,949,921 | 6,874,208 | Mar 30, 2023, 05:03 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 30, 2023 | Buy | $28.74 | 195,997 | 5,632,954 | 7,070,205 | Mar 30, 2023, 05:03 PM | |
| ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 24, 2023 | Buy | $16.25 | 2,461,538 | 39,999,993 | 11,081,584 | Mar 30, 2023, 05:00 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 24, 2023 | Buy | $26.87 | 192,335 | 5,168,042 | 6,409,928 | Mar 27, 2023, 05:01 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 27, 2023 | Buy | $27.48 | 151,132 | 4,153,107 | 6,561,060 | Mar 27, 2023, 05:01 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 23, 2023 | Buy | $26.67 | 155,089 | 4,136,224 | 6,217,593 | Mar 27, 2023, 05:01 PM | |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 14, 2023 | Buy | $16.00 | 1,250,000 | 20,000,000 | 1,867,229 | Feb 16, 2023, 05:04 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jan 20, 2023 | Buy | $13.00 | 1,923,076 | 24,999,988 | 11,609,704 | Jan 24, 2023, 04:30 PM | |
| HOWL | Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jan 06, 2023 | Buy | $2.21 | 1,853,000 | 4,095,130 | 5,701,056 | Jan 10, 2023, 05:14 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jan 04, 2023 | Buy | $7.28 | 180,703 | 1,314,806 | 9,686,628 | Jan 06, 2023, 04:39 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jan 03, 2023 | Buy | $4.00 | 629,297 | 2,516,055 | 3,880,021 | Jan 05, 2023, 04:43 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 27, 2022 | Buy | $5.99 | 4,089 | 24,510 | 9,505,925 | Dec 29, 2022, 05:00 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 19, 2022 | Buy | $5.90 | 98,787 | 582,814 | 9,501,836 | Dec 21, 2022, 04:30 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 15, 2022 | Buy | $5.49 | 237,029 | 1,302,474 | 8,061,629 | Dec 16, 2022, 04:41 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 16, 2022 | Buy | $5.42 | 1,341,420 | 7,269,826 | 9,403,049 | Dec 16, 2022, 04:41 PM | |
| FULC | Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 14, 2022 | Buy | $5.46 | 824,600 | 4,501,574 | 7,824,600 | Dec 16, 2022, 04:41 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 08, 2022 | Buy | $3.75 | 10,600 | 39,750 | 3,231,425 | Dec 12, 2022, 04:30 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Dec 09, 2022 | Buy | $3.93 | 19,299 | 75,845 | 3,250,724 | Dec 12, 2022, 04:30 PM | |
| VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Dec 09, 2022 | Option Exercise | $4.30 | 11,627,907 | 50,000,002 | 20,923,554 | Dec 09, 2022, 04:32 PM | |
| SLDB | Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Dec 02, 2022 | Option Exercise | $7.05 | 2,163,120 | 15,249,996 | 2,987,644 | Dec 05, 2022, 05:02 PM | |
| ACRV | Acrivon Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Nov 17, 2022 | Buy | $12.50 | 3,389,500 | 42,368,750 | 4,384,206 | Nov 21, 2022, 04:31 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 20, 2022 | Buy | $3.95 | 11,342 | 44,801 | 3,146,265 | Oct 24, 2022, 04:41 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 21, 2022 | Buy | $3.92 | 48,100 | 188,552 | 3,194,365 | Oct 24, 2022, 04:41 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 24, 2022 | Buy | $3.91 | 26,460 | 103,459 | 3,220,825 | Oct 24, 2022, 04:41 PM | |
| ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Oct 18, 2022 | Buy | $7.65 | 1,172,741 | 8,971,469 | 8,955,410 | Oct 20, 2022, 05:28 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 19, 2022 | Buy | $3.89 | 125,726 | 488,659 | 3,134,923 | Oct 19, 2022, 04:40 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 17, 2022 | Buy | $3.36 | 145,672 | 489,458 | 2,774,398 | Oct 19, 2022, 04:40 PM | |
| IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 18, 2022 | Buy | $3.76 | 234,799 | 882,844 | 3,009,197 | Oct 19, 2022, 04:40 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Oct 17, 2022 | Buy | $36.50 | 1,640,000 | 59,860,000 | 6,848,911 | Oct 19, 2022, 04:32 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 03, 2022 | Buy | $7.48 | 1,809 | 13,531 | 3,773,417 | Aug 05, 2022, 04:06 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 04, 2022 | Buy | $7.99 | 100 | 799 | 3,773,517 | Aug 05, 2022, 04:06 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 26, 2022 | Buy | $7.71 | 14,938 | 115,172 | 3,763,327 | Jul 28, 2022, 05:16 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 27, 2022 | Buy | $7.91 | 8,281 | 65,503 | 3,771,608 | Jul 28, 2022, 05:16 PM | |
| ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 01, 2022 | Buy | $3.55 | 2,816,900 | 9,999,995 | 7,782,669 | Jul 06, 2022, 05:27 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 21, 2022 | Buy | $7.99 | 302 | 2,413 | 3,748,389 | Jun 23, 2022, 04:31 PM | |
| WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director | Jun 16, 2022 | Buy | $2.15 | 9,480,052 | 20,382,113 | 17,202,009 | Jun 21, 2022, 04:33 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 13, 2022 | Buy | $7.90 | 20,000 | 158,000 | 3,686,663 | Jun 15, 2022, 04:25 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 14, 2022 | Buy | $7.97 | 61,424 | 489,402 | 3,748,087 | Jun 15, 2022, 04:25 PM | |
| KALA | Kala Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 26, 2022 | Sale | $0.36 | 1,005,686 | 365,667 | 7,039,613 | May 26, 2022, 05:09 PM | |
| KALA | Kala Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 23, 2022 | Sale | $0.65 | 1,250,000 | 812,500 | 9,624,613 | May 25, 2022, 05:17 PM | |
| KALA | Kala Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 24, 2022 | Sale | $0.51 | 144,805 | 73,851 | 9,479,808 | May 25, 2022, 05:17 PM | |
| KALA | Kala Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 25, 2022 | Sale | $0.42 | 1,434,509 | 602,494 | 8,045,299 | May 25, 2022, 05:17 PM | |
| PEPG | PepGen Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | May 10, 2022 | Buy | $12.00 | 3,229,200 | 38,750,400 | 6,621,680 | May 12, 2022, 07:06 PM | |
| NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Apr 26, 2022 | Buy | $15.00 | 2,200,000 | 33,000,000 | 7,805,129 | Apr 28, 2022, 04:32 PM | |
| ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 29, 2022 | Buy | $15.00 | 1,666,666 | 24,999,990 | 3,251,051 | Mar 31, 2022, 04:31 PM | |
| ICVX | Icosavax, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 28, 2022 | Buy | $4.53 | 175,318 | 794,611 | 5,953,665 | Mar 30, 2022, 04:31 PM | |
| ICVX | Icosavax, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 29, 2022 | Buy | $4.75 | 8,900 | 42,271 | 5,963,565 | Mar 30, 2022, 04:31 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 14, 2022 | Buy | $12.35 | 342,143 | 4,223,926 | 13,139,327 | Mar 16, 2022, 05:10 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 15, 2022 | Buy | $12.27 | 241,727 | 2,964,999 | 13,381,054 | Mar 16, 2022, 05:10 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 09, 2022 | Buy | $12.99 | 40,154 | 521,753 | 12,202,700 | Mar 11, 2022, 05:27 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 10, 2022 | Buy | $12.95 | 256,992 | 3,327,584 | 12,459,692 | Mar 11, 2022, 05:27 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 11, 2022 | Buy | $12.77 | 337,492 | 4,309,334 | 12,797,184 | Mar 11, 2022, 05:27 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 04, 2022 | Buy | $12.99 | 63,662 | 827,230 | 11,578,944 | Mar 08, 2022, 04:59 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 07, 2022 | Buy | $12.61 | 337,901 | 4,260,965 | 11,916,845 | Mar 08, 2022, 04:59 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 08, 2022 | Buy | $12.86 | 245,701 | 3,160,059 | 12,162,546 | Mar 08, 2022, 04:59 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 28, 2022 | Buy | $12.97 | 8,746 | 113,430 | 11,082,163 | Mar 02, 2022, 05:29 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 01, 2022 | Buy | $12.98 | 294,864 | 3,826,303 | 11,377,027 | Mar 02, 2022, 05:29 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 02, 2022 | Buy | $12.89 | 138,255 | 1,782,218 | 11,515,282 | Mar 02, 2022, 05:29 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 23, 2022 | Buy | $13.41 | 214,922 | 2,883,114 | 10,867,959 | Feb 25, 2022, 05:43 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 24, 2022 | Buy | $13.03 | 186,467 | 2,429,852 | 11,054,426 | Feb 25, 2022, 05:43 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 25, 2022 | Buy | $12.99 | 18,991 | 246,699 | 11,073,417 | Feb 25, 2022, 05:43 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 18, 2022 | Buy | $14.12 | 166,229 | 2,346,389 | 10,438,115 | Feb 22, 2022, 05:22 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 22, 2022 | Buy | $13.46 | 214,922 | 2,892,055 | 10,653,037 | Feb 22, 2022, 05:22 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 17, 2022 | Buy | $14.78 | 166,229 | 2,457,264 | 10,271,886 | Feb 22, 2022, 05:22 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 14, 2022 | Buy | $14.72 | 166,229 | 2,446,924 | 9,773,257 | Feb 16, 2022, 07:39 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 15, 2022 | Buy | $14.99 | 166,200 | 2,490,524 | 9,939,457 | Feb 16, 2022, 07:39 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 16, 2022 | Buy | $14.98 | 166,200 | 2,489,377 | 10,105,657 | Feb 16, 2022, 07:39 PM | |
| DICE | DICE Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2021 | Buy | $17.00 | 1,400,000 | 23,800,000 | 4,422,504 | Sep 20, 2021, 04:30 PM | |
| TYRA | Tyra Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2021 | Buy | $16.00 | 1,250,000 | 20,000,000 | 5,297,120 | Sep 17, 2021, 04:34 PM | |
| ELYM | Eliem Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Aug 12, 2021 | Buy | $12.50 | 3,200,000 | 40,000,000 | 10,599,586 | Aug 16, 2021, 04:47 PM | |
| ICVX | Icosavax, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Aug 02, 2021 | Buy | $15.00 | 2,666,666 | 39,999,990 | 5,140,679 | Aug 04, 2021, 04:31 PM | |
| CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Jul 27, 2021 | Buy | $17.00 | 2,950,000 | 50,150,000 | 7,913,537 | Jul 29, 2021, 04:30 PM |
Menu